Table 2 Clinical and laboratory characteristics at manifestation of children classified as T2DM separated accordingly to the presence of β‐cell autoantibodies.
No β‐cell autoantibodies | β‐cell autoantibodies | p value | |
---|---|---|---|
Number | 82 | 46 | |
Age | 13.9 (12.0 to 15.4) | 13.0 (10.9 to 15.4) | 0.365 |
Gender | 66% girls | 57% girls | 0.237 |
Non‐German origin | 15% | 11% | 0.520 |
BMI | 30.5 (25.6 to 35.3) | 30.0 (26.1 to 34.9) | 0.861 |
SDS BMI | 2.28 (1.68 to 2.91) | 2.39 (1.79 to 2.95) | 0.635 |
SDS weight | 2.10 (1.18 to 2.94) | 2.15 (1.70 to 3.14) | 0.428 |
HbA1c (%) | 8.0 (6.3 to 10.7) | 7.5 (6.3 to 10.4) | 0.575 |
Glucose (mg/dl) | 238 (149 to 314) | 251 (121 to 330) | 0.943 |
pH ⩽7.3 | 2% | 0% | 0.287 |
C‐peptide >1.5 ng/ml* | 33% | 28% | 0.586 |
Cholesterol (mg/dl) | 183 (155 to 211) | 173 (146 to 198) | 0.180 |
HDL cholesterol (mg/dl) | 42 (34 to 52) | 41 (36 to 49) | 0.973 |
Triglycerides (mg/dl) | 157 (96 to 248) | 128 (95 to 186) | 0.295 |
Systolic blood pressure (mm Hg) | 135 (121 to 145) | 131 (120 to 140) | 0.570 |
Diastolic blood pressure (mm Hg) | 80 (72 to 89) | 78 (70 to 89) | 0.334 |
Data presented as median (IQR) or percentages.
*Determined in the non‐ketotic state.